Minimally Effective Doses of Conventional Antipsychotic Medications Used to Treat Aggression, Self-Injurious and Destructive Behaviors in Mentally Retarded Adults
Authors:
- David S. JanowskyDJDavid S. Janowsky
- L. Jarrett BarnhillLBL. Jarrett Barnhill
- Mahesh ShettyMSMahesh Shetty
- John M. DavisJDJohn M. Davis
- 1 February 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 25 (1) , 19-25
Abstract
Retrospective review of records from 1990 to 1997 revealed unsuccessful attempts to withdraw antipsychotic medications from a total of 34 intellectually disabled individuals. The lowest dose of antipsychotic medication necessary to maintain symptom suppression and the dose at which relapse occurred were noted. Target behaviors observed indicating relapse included increased self-injurious behavior, aggression, and destructive/disruptive behaviors. Nineteen subjects received a low potency antipsychotic agent (ie, thioridazine or chlorpromazine) and 15 received a high potency antipsychotic agent (ie, haloperidol, loxapine, thiothixene). The mean lowest effective dose of chlorpromazine/thioridazine was 149.3 mg/d and relapse occurred at a mean dose of 93.6 mg/d. The mean lowest effective dose of haloperidol or related high potency drugs (expressed as haloperidol equivalents) was 5.9 mg/d, and relapse occurred at a mean dose of 3.8 mg/d.Keywords
This publication has 13 references indexed in Scilit:
- Dose Response and Dose Equivalence of AntipsychoticsJournal of Clinical Psychopharmacology, 2004
- Olanzapine for Self-Injurious, Aggressive, and Disruptive Behaviors in Intellectually Disabled AdultsThe Journal of Clinical Psychiatry, 2003
- A Multidose Study of Haloperidol Decanoate in the Maintenance Treatment of SchizophreniaAmerican Journal of Psychiatry, 2002
- Use of the atypical antipsychotics Olanzapine and Risperidone in adults with intellectual disabilityJournal of Intellectual Disability Research, 2000
- Risperidone Treatment of Children and Adolescents With Pervasive Developmental Disorders: A Prospective, Open-Label StudyJournal of the American Academy of Child & Adolescent Psychiatry, 1997
- A Study of the Clinical Outcome of Patients with Profound Mental Retardation Gradually Withdrawn from Chronic Neuroleptic MedicationAnnals of Clinical Psychiatry, 1995
- Optimal Dose of Neuroleptic in Acute SchizophreniaArchives of General Psychiatry, 1991
- Reduction in Antipsychotic Drug Dosage in Mentally Handicapped PatientsThe British Journal of Psychiatry, 1990
- Tardive dyskinesia in neuroleptic medicated mentally handicapped subjectsActa Psychiatrica Scandinavica, 1987
- What is the best maintenance dose of neuroleptics in schizophrenia?Psychiatry Research, 1980